VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes >> Research & Analysis>> Companies
The company overview page of Alembic Pharmaceuticals Ltd. shows financial information like live prices and stock quotes and technical charts on BSE and NSE. It also lists discussions for Alembic Pharmaceuticals Ltd. It features the latest news, fundamental analysis and technical analysis for Alembic Pharmaceuticals Ltd.

*The share prices have been adjusted for stock splits and dividends

Stock Recommendations for Alembic Pharmaceuticals Ltd.

Alembic Pharma: Business remains under pressure - assign SHORT
Equirus Securities | 14 Nov, 2017
Alembic Pharma’s (ALPM) 2QFY18 sales (-10% yoy to Rs 7.9bn) fell short of estimates due to below-expected US and domestic sales. However, EBITDA/PAT a...

Alembic Pharmaceuticals: Opportunities abound for future market growth
SPA Securities | 14 Sep, 2017
The company is aggressively investing in R&D and expansion, especially to build a strong US foothold. This includes a foray into niche areas like onco...

Alembic Pharma Q4FY17: Book partial profits and 'hold' on the remaining stock
Nirmal Bang | 05 May, 2017
Nirmal Bang believe that the company has successfully crafted a niche for itself in US markets and likely to remain a focus player. They recommend inv...

Competitors for Alembic Pharmaceuticals Ltd.

Company Current Price Book Value P/E Ratio Market Cap
(Rs. Cr.)
Lupin Ltd. 845.25 327.11 12.16 38,191.62
Ind-Swift Laboratories Ltd. 37.45 50.58 0.00 169.56
Kopran Ltd. 66.20 46.46 22.25 286.33
Granules India Ltd. 128.35 34.94 22.81 3,257.75
SMS Pharmaceuticals Ltd. 105.80 30.92 25.21 895.62

Experts Talk for Alembic Pharmaceuticals Ltd.

More >>

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: